Explore the latest industry trends shaping Early Access, Expanded Access, Managed Access and Compassionate Use Programmes across Europe and Global Markets.
From fragmented European regulatory pathways and paid early access models to real-world evidence generation, rare disease access and post-trial supply, these insights examine the issues driving discussion ahead of the 5th Operationalise: Early Access Programmes Summit Europe.
Europe’s Patchwork Early Access Landscape Is Forcing Pharma & Biotech Teams to Rethink How Programmes Are Planned, Launched & Scaled
From Compassionate Use to Launch Strategy: Early Access Programmes Are Becoming a Critical Part of Drug Development & Market Access Planning
Real-World Data from Early Access Programmes Is Reshaping Evidence Generation, Rare Disease Access & Launch Readiness
Explore the Agenda
Discover exactly how leading teams are solving the hardest Early Access challenges - from pathway selection and global delivery to data, supply, and long-term sustainability.
Partner With Us
Position your solutions in front of decision-makers actively looking to scale and optimise Early Access Programmes, and become a trusted partner in delivering access worldwide.
Join Early Access Leaders
Connect with the EAP community shaping how access is delivered today, exchange real challenges, and learn directly from peers running programmes across global markets.